Literature DB >> 17477394

Conformational analyses of a partially-folded bioactive prodomain of human furin.

Surajit Bhattacharjya1, Ping Xu, Ping Wang, Michael J Osborne, Feng Ni.   

Abstract

The 81-residue multifunctional prodomain of human furin adopts only a partially-folded conformational state under near physiological conditions. By use of NMR spectroscopy, we demonstrate that the N-terminal residues 1-46 of the prodomain in 50% trifluoroethanol (TFE) populates backbone conformations containing a short helix, a beta-strand and a helix-loop-helix super-secondary structure with elements of tertiary interactions. (15)N NMR relaxation measurements indicate that the helix-loop-helix region has similar motional characteristics in the fast picosecond to nanosecond timescales. On the other hand, the intervening segment (residues 47-65) is predominantly unstructured with a long and highly flexible region surrounding the protease 'activation loop' followed by a partially helical segment in the C-terminal end. Interestingly, the helix-loop-helix "fold" was found to be populated even when excised out of the full-length prodomain, since a peptide fragment derived from residues Pro16-Arg49 can also form the helix-loop-helix structure in aqueous solution in the absence of TFE. Structure analyses reveal that two helices orient in an antiparallel fashion directed by the sharing of hydrophobic residues involved in helix-capping interactions. Very importantly, a positively-charged Lys residue replacing His43 in the 16-49 fragment imparts stability to the super-secondary structure at both acidic and neutral pH, while a hydrophobic residue Leu at position 43 appears to destabilize the helical conformation in the 31-44 region. As such, this study provides valuable insights into the structural properties of the furin prodomain in relation to its role in the folding of the furin zymogen and its inhibitory action toward furin. (c) 2007 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17477394     DOI: 10.1002/bip.20748

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  6 in total

1.  The mechanism by which a propeptide-encoded pH sensor regulates spatiotemporal activation of furin.

Authors:  Danielle M Williamson; Johannes Elferich; Parvathy Ramakrishnan; Gary Thomas; Ujwal Shinde
Journal:  J Biol Chem       Date:  2013-05-07       Impact factor: 5.157

2.  Selective and potent furin inhibitors protect cells from anthrax without significant toxicity.

Authors:  Albert G Remacle; Katarzyna Gawlik; Vladislav S Golubkov; Gregory W Cadwell; Robert C Liddington; Piotr Cieplak; Sherri Z Millis; Roxane Desjardins; Sophie Routhier; Xue Wen Yuan; Witold A Neugebauer; Robert Day; Alex Y Strongin
Journal:  Int J Biochem Cell Biol       Date:  2010-03-01       Impact factor: 5.085

3.  A novel enediynyl peptide inhibitor of furin that blocks processing of proPDGF-A, B and proVEGF-C.

Authors:  Ajoy Basak; Abdel-Majid Khatib; Dayani Mohottalage; Sarmistha Basak; Maria Kolajova; Subhendu Sekhar Bag; Amit Basak
Journal:  PLoS One       Date:  2009-11-26       Impact factor: 3.240

4.  Autocatalytic activation of the furin zymogen requires removal of the emerging enzyme's N-terminus from the active site.

Authors:  Katarzyna Gawlik; Sergey A Shiryaev; Wenhong Zhu; Khatereh Motamedchaboki; Roxane Desjardins; Robert Day; Albert G Remacle; Boguslaw Stec; Alex Y Strongin
Journal:  PLoS One       Date:  2009-04-07       Impact factor: 3.240

5.  NMR structure and localization of a large fragment of the SARS-CoV fusion protein: Implications in viral cell fusion.

Authors:  Mukesh Mahajan; Deepak Chatterjee; Kannaian Bhuvaneswari; Shubhadra Pillay; Surajit Bhattacharjya
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-10-05       Impact factor: 3.747

Review 6.  Design, Engineering and Discovery of Novel α-Helical and β-Boomerang Antimicrobial Peptides against Drug Resistant Bacteria.

Authors:  Surajit Bhattacharjya; Suzana K Straus
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.